High Acute Myeloid Leukemia derived VEGFA levels are associated with a specific vascular morphology in the leukemic bone marrow

[1] Aguayo A(1999)Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia Blood 94 3717-3721

[2] Estey E(2000)Fractals and cancer Cancer Res. 60 3683-3688

[3] Kantarjian H(2002)Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from cancer to leukemia group B (CALGB 8461) Blood 100 4325-4336

[4] Mansouri T(1970)Role of the pericyte in wound healing. An ultrastructural study Exp. Mol. Pathol. 13 51-65

[5] Gidel C(2001)Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor Br. J. Haematol. 113 296-304

[6] Keating M(2009)AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance Blood 114 2869-2877

[7] Giles F(1995)The spontaneous expression of interleukin-1β and interleukin-6 is associated with spontaneous expression of AP-1 and NF-κB transcription factor in acute myeloblastic leukemia cells Leukemia (Baltimore) 9 425-432

[8] Estrov Z(2002)Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J. Clin. Oncol. 20 4368-4380

[9] Barlogie B(2003)A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia Blood 102 2763-2767

[10] Albitar M(1995)Angiogenesis in cancer, vascular, rheumatoid and other disease Nat. Med. 1 27-31

[1] Aguayo A(1999)Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia Blood 94 3717-3721

[2] Estey E(2000)Fractals and cancer Cancer Res. 60 3683-3688

[3] Kantarjian H(2002)Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from cancer to leukemia group B (CALGB 8461) Blood 100 4325-4336

[4] Mansouri T(1970)Role of the pericyte in wound healing. An ultrastructural study Exp. Mol. Pathol. 13 51-65

[5] Gidel C(2001)Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor Br. J. Haematol. 113 296-304

[6] Keating M(2009)AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance Blood 114 2869-2877

[7] Giles F(1995)The spontaneous expression of interleukin-1β and interleukin-6 is associated with spontaneous expression of AP-1 and NF-κB transcription factor in acute myeloblastic leukemia cells Leukemia (Baltimore) 9 425-432

[8] Estrov Z(2002)Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J. Clin. Oncol. 20 4368-4380

[9] Barlogie B(2003)A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia Blood 102 2763-2767

[10] Albitar M(1995)Angiogenesis in cancer, vascular, rheumatoid and other disease Nat. Med. 1 27-31